CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Oral Nutritional Supplementdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04754711
NCT04754711N/ACompleted
CompareCT.gov

Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition

Centre Hospitalier Régional d'Orléans·interventional·Posted Feb 15, 2021·Updated Apr 17, 2025

In Brief

A clinical study evaluating Oral Nutritional Supplement for Sickle Cell Disease and 2 related conditions. Completed, enrolled 72 participants across 1 site.

Detailed Summary

This study is design to assess the effects of an increase in nutritional intake on the bone mineral density of children with sickle cell disease, for 12 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSickle Cell Disease, Osteoporosis, Osteopenia
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 15, 2021
Enrollment StartSep 23, 2021
Primary CompletionMar 17, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 5.4 years ago

Interventions

Oral Nutritional Supplementdietary

We will propose to the patients of group 1 several different oral nutritional supplements according to taste, and consistency of each child in order to optimize observance. Each of those different oral nutritional supplements will be adapted to the nutritional survey and the age of children without exceeding recommended intake of proteins, carbohydrates, lipids and micronutrients. Those patients will consume the Oral Nutritional Supplement during 12 months.